News Gatherer
Community Support Team
|
|
Join Date: Dec 2007
Posts: 65,355
|
|
News Gatherer
Community Support Team
Join Date: Dec 2007
Posts: 65,355
|
Acorda to Focus on Developing Parkinson's Treatments CVT-301, Tozadenant - Parkinson'
Acorda to Focus on Developing Parkinson's Treatments CVT-301, Tozadenant
Parkinson's News Today
Acorda Therapeutics, which recently announced a corporate restructuring, will focus on the late-stage development of its two therapies for Parkinson's disease, CVT-301 and tozadenant. The news comes after a March 31 ruling by the U.S. District Court in ...
More...
|